Biological Industries

Company Overview

Snapshot

Founded in December 1990, Biological Industries operates with 51–200 employees. The company was acquired by Sartorius in May 2019.

Business overview

Biological Industries is a global supplier within the life sciences industry, specializing in cell culture media development and manufacturing. The company provides a range of products including cell culture media, supplements, and reagents for stem cell research, cell therapy applications, and serum-free media. Serving the biopharmaceutical industry, universities, government research organizations, and healthcare institutions, Biological Industries operates within the Health Tech & Life Sciences sector, focusing on areas such as biomaterials, tissue engineering, and medical devices.

Strategic signal

In December 2019, Sartorius acquired a majority stake in Biological Industries, a move that significantly expanded Sartorius's cell culture media portfolio. This acquisition signals a strategic consolidation within the life sciences market, enhancing Sartorius's capabilities in cell culture and positioning Biological Industries' products within a larger global framework.

Company Intelligence Q&A

What is Biological Industries' primary focus?

Biological Industries is a global supplier for the life sciences industry, specializing in cell culture media development and manufacturing for research and diagnostics.

When was Biological Industries founded?

Biological Industries was founded in December 1990.

What types of products does Biological Industries offer?

Biological Industries offers cell culture media, supplements, reagents for stem cell research and potential cell therapy applications, and serum-free media, including products like NutriFreez, AquaGuard, and MSCgo.

Which industries does Biological Industries serve?

Biological Industries supplies life science products to the biopharmaceutical industry, universities, government research organizations, and healthcare institutions globally.